Immunometabolic predictive factors in Merkel cell carcinoma (MCC) patients treated with avelumab.

被引：0
|
作者：
Badalamenti, Giuseppe
Incorvaia, Lorena
Algeri, Laura
Carreca, Ignazio Ugo
Brando, Chiara
Madonia, Giorgio
Peri, Marta
Cucinella, Alessandra
Perez, Alessandro
Barraco, Nadia
Russo, Tancredi Didier Bazan
Pomi, Federica Li
Carreca, Anna Paola
Gristina, Valerio
Galvano, Antonio
Iovanna, Juan
Fanale, Daniele
Bazan, Viviana
Russo, Antonio
Carreca, Ignazio Ugo
机构：
[1] Univ Palermo, Sect Med Oncol, Dept Surg Oncol & Oral Sci, Palermo, Italy
[2] Univ Sch Med, Palermo, Italy
[3] Univ Palermo, Dept Surg Oncol & Oral Sci, Palermo, Italy
[4] Univ Sch Med, Messina, Italy
[5] Inserm, U624 Stress Cellulaire, Marseille, France
[6] Univ Palermo, Palermo, Italy
[7] E Majorana Fdn Ctr Sci Culture, Int Sch Med Sci, Geneva, Switzerland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21525
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Integrative molecular analysis of metastatic Merkel cell carcinoma to identify predictive biomarkers of response to avelumab.
    Georges, Sara
    Shah, Parantu K.
    Shapiro, Irina
    Hicking, Christine
    Lu, Lei
    Hennessy, Meliessa
    D'Angelo, Sandra P.
    Cai, Ti
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [2] Augmentation of adoptive T-cell therapy for Merkel cell carcinoma with avelumab.
    Paulson, Kelly Garneski
    Perdicchio, Maurizio
    Kulikauskas, Rima
    Wagener, Felecia
    Church, Candice
    Bui, Kieu-Thu
    Vandeven, Natalie
    Thomas, Hannah
    McAfee, Megan
    Miller, Natalie
    Chin, Kevin M.
    Su, Zhen
    Greenberg, Philip D.
    Parvathaneni, Upendra
    Bhatia, Shailender
    Nghiem, Paul
    Chapuis, Aude
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [3] Body mass index and baseline platelet count as predictive factors in Merkel cell carcinoma patients treated with avelumab
    Incorvaia, Lorena
    Dimino, Alessandra
    Algeri, Laura
    Brando, Chiara
    Magrin, Luigi
    De Luca, Ida
    Pedone, Erika
    Perez, Alessandro
    Sciacchitano, Roberta
    Bonasera, Annalisa
    Russo, Tancredi Didier Bazan
    Li Pomi, Federica
    Peri, Marta
    Gristina, Valerio
    Galvano, Antonio
    Giuffrida, Dario
    Fazio, Ivan
    Toia, Francesca
    Cordova, Adriana
    Florena, Ada Maria
    Giordano, Antonio
    Bazan, Viviana
    Russo, Antonio
    Badalamenti, Giuseppe
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [4] Clinical characteristics and survival of patients with advanced Merkel cell carcinoma (MCC) treated with avelumab: Analysis of a prospective German MCC registry (MCC TRIM)
    Becker, J. C.
    Mahmoudpour, S.
    Schadendorf, D.
    Leiter-Stoppke, U.
    Meier, F.
    Herbst, R.
    Sachse, M.
    Grabbe, S.
    Gebhardt, C.
    Ziller, F.
    Pfoehler, C.
    Mohr, P.
    Zimmer, L.
    Boutmy, E.
    Hoff, S.
    Verpillat, P.
    Milano, A. Fernandez
    Shlaen, M.
    Fu, C.
    Ugurel-Becker, S.
    ANNALS OF ONCOLOGY, 2023, 34 : S685 - S686
  • [5] Predicting overall survival in patients (pts) with treatment-naive metastatic Merkel cell carcinoma (mMCC) treated with avelumab.
    Bullement, Ash
    D'Angelo, Sandra P.
    Amin, Amerah
    Stapelkamp, Ceilidh
    Willis, Anna
    Lilley, Cameron
    Hatswell, Anthony
    Bharmal, Murtuza
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [6] Clinical Characteristics and Survival Data of Patients with advanced Merkel Cell Carcinoma (MCC) treated with Avelumab: Analysis of a prospective German MCC Registry (MCC TRIM)
    Becker, J. C.
    Mahmoudpour, S. H.
    Schadendorf, D.
    Leiter-Stoeppke, U.
    Meier, F.
    Herbst, R.
    Sachse, M. M.
    Grabbe, S.
    Gebhardt, C.
    Ziller, F.
    Pfoehler, C.
    Mohr, P.
    Zimmer, L.
    Boutmy, E.
    Hoff, S.
    Verpillat, P.
    Milano, A. Fernandez
    Shlaen, M.
    Fu, C.
    Ugurel, S.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2024, 22 : 11 - 12
  • [7] Association between objective responses (OR) and overall survival (OS) in patients (pts) with metastatic Merkel cell carcinoma (mMCC) treated with avelumab.
    D'Angelo, Sandra P.
    Hunger, Matthias
    Schlichting, Michael
    Hennessy, Meliessa G.
    Bharmal, Murtuza
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [8] Survival Analysis in Patients with Metastatic Merkel Cell Carcinoma Treated with Avelumab
    Tereza Lanitis
    Irina Proskorovsky
    Apoorva Ambavane
    Matthias Hunger
    Ying Zheng
    Murtuza Bharmal
    Hemant Phatak
    Advances in Therapy, 2019, 36 : 2327 - 2341
  • [9] Survival Analysis in Patients with Metastatic Merkel Cell Carcinoma Treated with Avelumab
    Lanitis, Tereza
    Proskorovsky, Irina
    Ambavane, Apoorva
    Hunger, Matthias
    Zheng, Ying
    Bharmal, Murtuza
    Phatak, Hemant
    ADVANCES IN THERAPY, 2019, 36 (09) : 2327 - 2341
  • [10] Merkel cell carcinoma (MCC)
    Fiedler, Eckhard
    Lange, Danica
    Marsch, Wolfgang Ch.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2011, 9 : 10 - 10
12345